Simon Pedder - 08 Sep 2025 Form 4 Insider Report for ADAPTIN BIO, INC.

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
10 Sep 2025, 16:59:40 UTC
Prior SEC filing
18 Feb 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ S. Halle Vakani, Attorney-in-Fact

Key filing fact

Simon Pedder filed Form 4 for ADAPTIN BIO, INC. on 10 Sep 2025.

Key facts

  • This page summarizes Simon Pedder's Form 4 filing for ADAPTIN BIO, INC..
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 10 Sep 2025, 16:59.

Change

  • Previous filing in this sequence was filed on 18 Feb 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001316736 Primary reporting owner

Pedder Simon

Relationship
Executive Chairman, Director, 10%+ Owner
Address
3540 TORINGDON WAY, SUITE 200, #250, CHARLOTTE
Signature
/s/ S. Halle Vakani, Attorney-in-Fact
Signature date
10 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

No ticker holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
928,571
Date
08 Sep 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

No ticker transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+192,231
Change %
Price
$0.000000
Shares after
192,231
Date
08 Sep 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
192,231
Exercise price
$4.40
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests in equal monthly installments on the last day of each calendar month over 48 months beginning on September 8, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .